Governor Hogan

Governor’s Briefing on COVID-19: April 1, 2021

Starting today, ALL Marylanders age 16+ can now pre-register for the vaccine, with eligibility phases expected to accelerate; 75% of residents age 65+ have been vaccinated, federal mobile vaccination units and more vaccination sites are coming soon.

Governor’s Briefing on COVID-19: March 2, 2021

Hogan announced Dr. Robert Redfield, former director of the Centers for Disease Control and Prevention, will join Maryland’s COVID-19 team, and provided updates about the Johnson & Johnson vaccine and more mass vaccination sites.

Governor’s Briefing on COVID-19: January 26, 2021

While supply continues to be limited with only 10,000 doses available each day, Hogan is expanding Phase 1 of vaccine distribution to include those who are severely immunocompromised. Mobile clinics and mass vaccination sites with National Guard support are coming soon.

Governor Hogan Press Conference: January 21, 2021

With experts insisting that in-person instruction does not increase community spread or hospitalizations, and COVID-19 numbers beginning to plateau since introduction of the vaccine, Governor Hogan urges schools to get kids in classrooms no later than March 1.

Governor Hogan Proposes $1 Billion RELIEF Act

As Governor Hogan unveils the Fiscal Year 2022 budget, he proposes the $1 Billion RELIEF Act – Recovery for the Economy, Livelihoods, Industries, Entrepreneurs, and Families Act – which includes direct stimulus payments to Marylanders.

Governor’s Briefing on COVID-19: January 14, 2021

Governor Hogan announced an expedited rollout of the vaccine in Maryland – moving Phase 1B up to Monday 1/18 for ages 75+, assisted living residents and adding K-12 teachers, staff and child care providers. Phase 1C (ages 65-74) to begin Monday 1/25.

Latest Insights

View All

Nemphos Braue Adds Three to the Team

With a focus on providing boutique-style service to its corporate and business law clients, Nemphos Braue has added three additional team members to support the firm’s continued growth.